Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Antisense modulators of EGR-1 expression patented by Isis

July 20, 2000

Antiinflammatory effects of new A2A agonist DWH-146e described at Purines 2000

July 18, 2000

SNAP-7915: a promising new therapy for BPH designed by Synaptic and Merck team

July 17, 2000

New formulations of RenaGel approved for use by FDA

July 17, 2000

Interim results of phase III Synsorb Pk trial disappointing

July 14, 2000

Invicorp upgraded to partial clinical hold in U.S.; full approval received in New Zealand

July 14, 2000

MacroChem to begin phase III home trial of Topiglan

July 13, 2000

Combination of natural ingredients as a potential new treatment for prostatitis

July 7, 2000

Sibutramine demonstrates efficacy in urinary incontinence

July 5, 2000

TAP withdraws Uprima NDA until further data available

July 5, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...